BiomeSense
Charles Chiu, MD, Ph.D., is a pioneer in using metagenomic analysis for diagnostic and clinical research. An infectious disease physician and microbiologist, he leads a translational research laboratory that has successfully identified and characterized emerging viral pathogens. Charles and his lab have also led the way in discovering new approaches to applying bioinformatics and genomic technologies for clinical and public health applications.
Charles currently leads the Precision Diagnosis of Acute Infectious Diseases study. Its goal is to make metagenomic next-generation sequencing for pathogen detection clinically available for the first time. Charles has been interviewed by several media outlets regarding the coronavirus, including a recent article for Time magazine.
This person is not in the org chart
This person is not in any offices
BiomeSense
BiomeSense is revolutionizing human microbiome research by creating novel tools to track, analyze, and store daily microbiome profiles of clinical trial participants, providing vastly more data than is possible with current tools, all for a fraction of the cost. This gives investigators far deeper insight into how the microbiome influences and is influenced by clinical interventions.